Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01545193 · ClinicalTrials.gov registry record

The Effect of Age on the Incidence of Postoperative Residual Neuromuscular Blockade

A clinical trial, sponsored by Endeavor Health.

Completed
Registry status
300
Enrollment target

NCT01545193 is a clinical trial that has completed, run by Endeavor Health. The registered enrollment target is 300 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01545193 has completed, sponsored by Endeavor Health.

COMPLETED
Registry status
300 participants
Enrollment target

Study Summary

Residual neuromuscular blockade is frequently observed in the early postoperative period when patients have received a general anesthetic with muscle relaxants. At the present time it is uncertain whether certain patient populations are at greater risk for this common anesthetic complication. However, it is possible that elderly surgical patients may exhibit a higher incidence of residual neuromuscular blockade. The aim of this clinical trial is to determine the incidence of residual neuromuscular blockade in a cohort of younger (ages 18-50) and older (ages 70-90) patients undergoing surgery and general anesthesia.

Interventions

  • OTHER Age and incidence of residual neuromuscular blockade

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2011-06
Est. Completion 2014-09

Sponsor

Endeavor Health

94 total trials

What the Registry Record Tells You About NCT01545193

The ClinicalTrials.gov registry entry for NCT01545193 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Endeavor Health, which has 94 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Age and incidence of residual neuromuscular blockade is the first listed.

NCT01545193 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01545193 about?

NCT01545193 is a clinical study titled "The Effect of Age on the Incidence of Postoperative Residual Neuromuscular Blockade". Residual neuromuscular blockade is frequently observed in the early postoperative period when patients have received a general anesthetic with muscle relaxants. At the present time it is uncertain whether certain patient populations are at greater risk for this common anesthetic complication. Howeve...

What is the current status of trial NCT01545193?

This trial is currently completed. The enrollment target is 300 participants. The study started on 2011-06. Estimated completion is 2014-09.

What interventions are being tested in trial NCT01545193?

The interventions under investigation include: Age and incidence of residual neuromuscular blockade (OTHER).

Who is sponsoring clinical trial NCT01545193?

This trial is sponsored by Endeavor Health, which has 94 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.